MM&M

OPDP doubles up on ARS’s Neffy

The FDA’s Office of Prescription Drug Promotion (OPDP) has issued a pointed warning to ARS Pharmaceutical Operations, calling its direct-to-consumer television advertisement for Neffy (epinephrine ...
Nasdaq

ARS Pharmaceuticals Announces U.S. Availability of neffy® (epinephrine nasal spray), the First and Only Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis

Visit neffy.com to “Get neffy Now” and access the comprehensive patient assistance programs available through neffyConnect ARS Pharmaceuticals has also submitted a supplemental New Drug Application ...
Women's Health

What To Know About Neffy, The Needle-Free EpiPen Alternative Just Approved By the FDA

For years, people with severe allergies have been prescribed an epinephrine autoinjector in case of emergency situations. But these injectors—which include the popular EpiPen—involve jabbing a needle ...
Yahoo

FDA declines approval bid for Neffy, a needle-free EpiPen alternative

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration on Tuesday did not approve Neffy, an epinephrine nasal spray from drugmaker ARS Pharmaceuticals, ...
The Globe and Mail

neffy® (epinephrine nasal spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

neffy offers a new delivery method for epinephrine in Canada for adults and children (>30 kg) living with severe allergic reactions ALK- Abelló A/S, which licenses the rights to market neffy in Canada ...
Mercury News

Forget EpiPens. This California biotech is offering the same medicine without needles

Alyssa Bauder was just learning how to read, but she had already memorized the colors of food packaging that spelled danger for her: peanuts. The 6-year-old knew to stay away from chocolate dressed in ...
Nasdaq

California K-12 Schools Now Eligible for neffyinSchools Program, Offering Needle-Free Epinephrine at No Cost for Emergency Use

SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect ...
Healio

Q&A: Company seeks to expand neffy FDA approval to more pediatric patients

Please provide your email address to receive an email when new articles are posted on . Children as young as age 10 years are able to self-administer neffy 1 mg. ARS Pharmaceuticals is also working on ...
KTVU

FDA approves neffy nasal spray as alternative to EpiPen

The nasal spray, marked as neffy, is intended as an emergency treatment for severe allergic reactions. Neffy is the first needle-free alternative to shots like EpiPen. The FDA said it approved the ...
Seeking Alpha

ARS Pharmaceuticals, Inc. (SPRY) ARS Pharmaceuticals neffy (epinephrine nasal spray) FDA Approval Conference Call Transcript

Good day and welcome to the ARS Pharmaceuticals' neffy (epinephrine nasal spray) FDA Approval Conference call. At this time, all participants are in listen-only mode. After the speakers’ presentation, ...
KRON4 News

ARS Pharmaceuticals Announces U.S. Availability of neffy® (epinephrine nasal spray), the First and Only Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis

SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect ...